Intravitreal triamcinolone acetonide(steroid) injection for the treatment of retinal disease

Intravitreal triamcinolone acetonide injection for the treatment of cystoid macular edema in patients presenting to tertiary eye care center of central india:A prospective study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081840

Enrollment

Registered

2025-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: intravitreal triamcinolone acetonide injection 4mg/ 0.1ml: intravitreal triamcinolone acetonide injection 4mg/ 0.1ml intravitreal route of administratin in pars plana area,given monthly

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with cystoid macular edema. patients willing to participate.

Exclusion criteria

Exclusion criteria: Patients with history of glaucoma. history of eye injury

Design outcomes

Primary

Measure	Time frame
central macular thickness and visual acuity.Timepoint: 4 weeks ,3months,6months	—

Secondary

Measure	Time frame
improvement in best corrected visual acuity.Timepoint: at day 1,15th day,4weeks & 3months,6months	—

Countries

India

Contacts

Public ContactDr. Shweta sanjiv chopade

Government medical college,Nagpur.

drkavitad1423@yahoo.com9423105181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026